Health Sciences Group, Inc. (HESG) Stock
Operating through its various subsidiaries, Health Sciences Group Inc. (HESG) specializes in supplying a range of ingredients and finished products for the nutritional supplement and functional food and beverage sectors across the United States.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Health Sciences Group, Inc.
Operating through its various subsidiaries, Health Sciences Group Inc. (HESG) specializes in supplying a range of ingredients and finished products for the nutritional supplement and functional food and beverage sectors across the United States. Key among its offerings is Shugr, an innovative, calorie-free sugar alternative meticulously formulated to replicate the taste and baking properties of traditional cane sugar. Another notable product is the Sequesterol Advance Cardio Formula, a proprietary blend featuring clinically validated ingredients designed to support robust cardiovascular well-being and maintain optimal blood circulation. The company's portfolio further includes Aplevia, an antioxidant extracted from apple peels, and Edible Sponges, an open-cell hydrocolloid product. Distribution channels for these products are diverse, encompassing major retail chains — such as mass merchandisers, pharmacies, grocery stores, and discount outlets — alongside sales to healthcare professionals, practitioners, and various other media platforms. Tracing its origins to 1996 as Centurion Properties Development Corporation, the company underwent a name change to iGoHealthy.com in 2000, before adopting its current designation, Health Sciences Group, Inc., in 2001. Its corporate headquarters are situated in Newport Beach, California.
Health Sciences Group, Inc. (HESG) stock trades at $0.00 with a market capitalization of $1.87M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 1.87, price-to-sales of 4.06. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, Health Sciences Group, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of -9.14%, an operating margin of -15.20%, a net profit margin of 0.00%.
Official website: www.healthsciencesgroup.com